Skip to content

KSMC Laboratories

Active
Private limited companyfounded 201016 yrs activeMarsveldplein 5, 1050 Elsene, BelgiumKBO/BCE: BE 0825.580.064

KSMC Laboratories has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €194k and a net result of €14k. Equity is growing by ~9.1% per year across the filed fiscal years. Its solvency ranks better than 25% of 6007 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 1.1% (low).

Checked score

Score 2024
64 / 100
Healthy= vs 2023
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability36▲+21
Solvency32▼-6
Growth52=
Stability100
Bankruptcy probability, 12 months
1.1% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €12k at 30 days acceptable
Liquidity tight (current ratio 1.24 against 1.29 in 2023), and 79.3% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 16 years 0 20 y
neutral · Filed after the deadline
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 19-08-2025, 19 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
not confirmed
2024
19 d late
2023
84 d late
2022
31 d late
2021
31 d late
2020
29 d late
2019
9 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2024, full schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€14k▲ 158%
2023 · €5k
2018: €45k 2019: €31k 2020: €109k 2021: €-492 2022: €1k 2023: €5k
2018 → 2024
Working capital
€181k▲ 1.4%
2023 · €178k
2018: €58k 2019: €114k 2020: €172k 2021: €172k 2022: €180k 2023: €178k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20202021202220232024Trend
Equity€174k-€173k▼ 0.3%€174k▲ 0.6%€180k▲ 3.1%€194k▲ 7.9%
Operating result€140k-€5k▼ 96.1%€10k▲ 78.2%€19k▲ 95.4%€33k▲ 72.3%
Net result€109k-€-492€1k€5k▲ 416%€14k▲ 158%
Result per fiscal year
Operating resultNet result
€-50k€0€50k€100k€150kOperating result 2020: €140k€140kNet result 2020: €109k€109kOperating result 2021: €5k€5kNet result 2021: €-492€-492Operating result 2022: €10k€10kNet result 2022: €1k€1kOperating result 2023: €19k€19kNet result 2023: €5k€5kOperating result 2024: €33k€33kNet result 2024: €14k€14k20202021202220232024
After the dip in 2021 the operating result has climbed three years in a row; 2024 is 72% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €936k
Fixed assets €13k▼ 2.7%
Current assets €923k▲ 17.7%
Equity and liabilities €936k
Equity €194k▲ 7.9%
Debt €742k▲ 20.1%
The debt ratio rises from 77.4% to 79.3%: debt grows faster than equity.
Key figures and ratios
2024 value · change against 2023
EBITDA
€33k
2023 · €20k
Cash flow
€15k
2023 · €6k
Solvency
20.7%
2023 · 22.6%
Current ratio
1.24
2023 · 1.29
Quick ratio
1.04
2023 · 1.03
Debt / equity
3.82
2023 · 3.43
ROE
7.3%
2023 · 3.0%
ROA
1.5%
2023 · 0.7%
Interest coverage
2.09
2023 · 2.16
Debt
€742k
2023 · €618k
Debt ≤ 1 year
€742k
2023 · €606k
Income taxes
€3k
2023 · €5k
Staff costs
€4k
2023 · €677
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet Code20232024
Assets
Total assets20/58€798k€936k
Fixed assets21/28€14k€13k
Tangible fixed assets22/27€12k€11k
Furniture and vehicles24€12k€11k
Financial fixed assets28€2k€2k=
Current assets29/58€784k€923k
Stocks and contracts in progress3€161k€149k
Stocks30/36€161k€149k
Amounts receivable within one year40/41€535k€747k
Trade receivables40€503k€690k
Other amounts receivable41€32k€57k
Current investments50/53€3k€3k=
Cash at bank and in hand54/58€84k€21k
Deferred charges and accrued income490/1€2k€3k
Equity and liabilities
Total equity and liabilities10/49€798k€936k
Equity10/15€180k€194k
Contributions10/11€50k€50k=
Capital10€50k€50k=
Issued capital100€50k€50k=
Reserves13€5k€5k=
Non-distributable reserves130/1€5k€5k=
Legal reserve130€5k€5k=
Profit (loss) carried forward14€125k€139k
Amounts payable17/49€618k€742k
Amounts payable after more than one year17€12k-
Financial debts170/4€12k-
Amounts payable within one year42/48€606k€742k
Current portion of amounts payable after more than one year42€38k€44k
Financial debts43-€34k
Credit institutions430/8-€34k
Trade debts44€468k€477k
Suppliers440/4€468k€477k
Advances received on contracts in progress46€10k€104k
Taxes, remuneration and social security45€40k€34k
Taxes450/3€40k€32k
Remuneration and social security454/9-€2k
Other amounts payable47/48€50k€50k=
Income statement Code20232024
Remuneration, social security and pensions62€677€4k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€370€370=
Other operating charges640/8€4k€2k
Non-recurring operating charges66A-€37k
Gross operating margin9900€24k€76k
Operating profit (loss)9901€19k€33k
Financial income75/76B€27€8
Recurring financial income75€27€8
Financial charges65/66B€9k€16k
Recurring financial charges65€9k€16k
Profit (loss) for the period before taxes9903€10k€17k
Income taxes67/77€5k€3k
Profit (loss) for the period9904€5k€14k
Profit (loss) for the period to be appropriated9905€5k€14k
Appropriation of the result
Profit (loss) to be appropriated9906€125k€139k
Profit (loss) brought forward from the previous period14P€119k€125k
Social balance
Average headcount (FTE)9087-1.0

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2025
19-08
NBB filing Annual accounts filed
fiscal year 2024 · full schema · 19 days late
2024
23-10
NBB filing Annual accounts filed
fiscal year 2023 · full schema · 84 days late
2023
31-08
NBB filing Annual accounts filed
fiscal year 2022 · full schema · 31 days late
2022
31-12
Financial Back to profitnet €1k
Net result €1k after one loss-making year.
31-08
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 31 days late
2021
31-12
Financial Weakest financial yearnet €-492 ▼100%
Net result drops to €-492, the lowest in the series; recovery starts the following year.
29-08
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 29 days late
2020
31-12
Financial Highest result since 2018net €109k ▲255%
Operating result €140k, net result €109k, both a record.
31-12
Financial Equity above €150kEq €174k ▲50.8%
3 profitable years in a row build equity to €174k.
22-07
NBB filing Annual accounts filed
fiscal year 2019 · full schema
2019
31-12
Financial Equity above €100kEq €115k ▲36.1%
2 profitable years in a row build equity to €115k.
27-08
NBB filing Annual accounts filed
fiscal year 2018 · full schema · 27 days late
2018
27-09
NBB filing Annual accounts filed
fiscal year 2017 · full schema · 58 days late
2017
08-08
NBB filing Annual accounts filed
fiscal year 2016 · full schema · 8 days late
2016
18-08
NBB filing Annual accounts filed
fiscal year 2015 · full schema · 18 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Elsene · 1 establishment unit since 2011
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Marsveldplein 51050 Elsene
Ground area
3,724 m²
Building footprint
1,306 m²
Volume, LiDAR
98,133 m³
Parcel 21009A0769/00S002, Brussels · tallest building 99.0 m, ±27 floors. Linked by address, not a title deed.
1 establishment unit
KSMC Laboratories SRL
Marsveldplein 5, 1050 ElseneWholesale trade
since 20112.204.395.571
1 parcel
Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21009A0769/00S002 Brussels 3,724 m² 1 · 1,306 m² 99.0 m · 27 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Elsene2.204.395.571
2 permissions
Groothandelaar petfood · since 13-12-2019
Groothandelaar LM>3 maand · since 14-08-2012

Similar companies · same sector, comparable size

Of 1,733 companies in sector 46150 we hold annual accounts for 750. 543 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded03-05-2010
Fiscal year end31-12
Abbreviation FR KSMC
Activities, NACEBEL
46150Agents in the wholesale of furniture, household goods and hardware
01479Crop and animal production, hunting and related service activities
10890Manufacture of food products
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
46190Agents in non-specialised wholesale trade
46450Wholesale of perfume and cosmetics
72109Other research and development on natural sciences
82920Office administrative, office support and other business support activities
86909Human health activities
86995Nutrition and dietetics services
Sources
Crossroads Bank for EnterprisesNational Bank · 15 filingsAddress and cadastre registers

Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.

Contact details

1 entry
Website:www.ksmc.eu
Establishment Elsene 2.204.395.571